Modern clinical research on LSD

Liechti, Matthias E·2017·Neuropsychopharmacology
DOI 10.1038/npp.2017.86

Cited by (236)

Items 101–200 of 236

  1. Self-inflicted neck wounds under influence of lysergic acid diethylamide
    Brendan Le Daré, Thomas Gicquel, Alain Baert, Isabelle Morel, Renaud Bouvet · 2020 · Medicine
  2. Pattern Breaking: A Complex Systems Approach to Psychedelic Medicine
    Inês Hipólito, Jonas Mago, Fernando E. Rosas, Robin Lester Carhart-Harris · 2022
  3. Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT2A receptor
    Étienne Billard, Alexandre G. Torbey, Antonio Inserra, Emily Grant, Antonella Bertazzo, Danilo De Gregorio, Stefano Comai, David Chatenet, Gabriella Gobbi, Terence E. Hébert · 2025 · Cellular Signalling
  4. Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice
    Shelby A. McGriff, Jacquelin C Hecker, Alexander D. Maitland, John S. Partilla, Michael H. Baumann, Grant C. Glatfelter · 2025 · Psychopharmacology
  5. Unveiling GABA and Serotonin Interactions During Neurodevelopment to Re-Open Adult Critical Periods for Neuropsychiatric Disorders
    Emanuela Beretta, Gianmarco Cuboni, Gabriele Deidda · 2025 · International Journal of Molecular Sciences
  6. A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects
    Patrick C. Dolder, Edna Grünblatt, Felix Müller, Stefan Borgwardt, Matthias E. Liechti · 2017 · Frontiers in Pharmacology
  7. Microdosing with classical psychedelics: Research trajectories and practical considerations
    Alice Wong, Amir Raz · 2022 · Transcultural Psychiatry
  8. Non-classical behavior of the default mode network regions during an information processing task
    Pedro Henrique Rodrigues da Silva, Carlo Rondinoni, Renata Ferranti Leoni · 2020 · Brain Structure and Function
  9. The possible place for psychedelics in pharmacotherapy of mental disorders
    Adam Wojtas · 2023 · Pharmacological Reports
  10. 5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence
    Guy A. Higgins, Edward M. Sellers · 2021 · Progress in brain research
  11. Effects of serotonergic psychedelics on mitochondria: Transdiagnostic implications for mitochondria-related pathologies
    Patrick Fissler, Anja Vandersmissen, Marco Filippi, Rezan Nehir Mavioğlu, Felix Scholkmann, Alexander Karabatsiakis, Rainer Krähenmann · 2023 · Journal of Psychopharmacology
  12. Kétamine, psilocybine, et antidépresseurs d'action rapide : de nouvelles promesses pour la psychiatrie?
    Hugo Bottemanne, Anne Claret, Philippe Fossati · 2020 · L Encéphale
  13. A cluster of lysergic acid diethylamide (LSD) poisonings following insufflation of a white powder sold as cocaine
    Darren M. Roberts, Kulanka H. Premachandra, Betty S H Chan, Robin Auld, Thanjira Jiranantakan, Christopher Ewers, Catherine McDonald, Vanessa Shaw, Jared A Brown · 2021 · Clinical Toxicology
  14. Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis
    Tim Hirschfeld, Laura Alexandra Smit‐Rigter, Daan van der Gouwe, Simon Reiche, Heino Stöver, Tomislav Majić · 2021 · Current Addiction Reports
  15. A cluster of 25B-NBOH poisonings following exposure to powder sold as lysergic acid diethylamide (LSD)
    Sean T. Ivory, Joe‐Anthony Rotella, Jennifer Schumann, Shaun L. Greene · 2022 · Clinical Toxicology
  16. The Resurgence of Hallucinogen Drugs in Clinical Research
    Maria Teresa Rivera-Garcia, Silvia Lorenia Cruz · 2023 · Revista de investigaci�n Cl�nica
  17. Serotonin 2A (5-HT2A) receptor as evolving biological target: function, structure, ligands and role in the therapy of neuropsychiatric diseases
    Monika Fryc, Daria Kluzik, Anna Czopek, Jakub Jończyk, Agnieszka Zagórska · 2025 · Neuropharmacology
  18. Therapeutic Potential of Psychedelics in the Treatment of Psychiatric Disorders, Part 1
    Avinash Hosanagar, Joseph Michael Cusimano, Rajiv Radhakrishnan · 2021 · The Journal of Clinical Psychiatry
  19. Classic psychedelics do not affect T cell and monocyte immune responses
    Deborah Rudin, Alexander Areesanan, Matthias E. Liechti, Carsten Gründemann · 2023 · Frontiers in Psychiatry
  20. Cross-validation of the ego dissolution scale: implications for studying psychedelics
    Steven Jay Lynn, Charlie W. McDonald, Fiona G. Sleight, Richard E. Mattson · 2023 · Frontiers in Neuroscience
  21. Psychedelic-augmented psychotherapy for overcoming traumatic dissociation: A review of neuroscientific and phenomenological evidence
    Ansgar Rougemont-Bücking, Florence Guenot, Virginie Salamin, Isabelle Gothuey, Catherine Duffour, Julia King-Olivier, Vincent Girard, Jean Naudin · 2024 · European Journal of Trauma & Dissociation
  22. Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide in healthy participants within a novel intervention paradigm: Qualitative results from a proof-of-concept study
    Peter S. Hendricks, Heith Copes, Neiloufar Family, Luke T. J. Williams, David P. Luke, Shlomi Raz · 2022 · Journal of Psychopharmacology
  23. Mystical and Ego-Dissolution Experiences in Ayahuasca and Jurema Holistic Rituals: An Exploratory Study
    Robson Savoldi, Antônio Roazzi, Rita Clara de Oliveira Sales · 2023 · International Journal for the Psychology of Religion
  24. Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential
    Priyanshu Raj, Shyambabu P. Rauniyar, Bhagyesh Sapkale · 2023 · Cureus
  25. Cannabis points to the synaptic pathology of mental disorders: how aberrant synaptic components disrupt the highest psychological functions
    Paul D. Morrison, Robin M. Murray · 2020 · Dialogues in Clinical Neuroscience
  26. Therapeutic Use of Hallucinogens
    Victor Distefano Wiltenburg, Dianne da Rocha Prado, Fúlvio Rieli Mendes · 2021 · Springer eBooks
  27. The potential role of lysergic acid diethylamide for psychological assisted therapy: A meta‐analysis of randomised controlled trials in healthy volunteers
    Hang Li, Yi Zhong, Siyuan Yang, Jiahe Wang, Xiang Li, Jianguo Xu, Heng Gao, Gang Chen · 2021 · Human Psychopharmacology Clinical and Experimental
  28. Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland
    Tatiana Aboulafia Brakha, A. Buchard, Cédric Mabilais, Sylvie Alaux, Caroline Amberger, L. Furtado, Federico Seragnoli, Jean-François Briefer, Gabriel Thorens, Michel Sabé et al. · 2026 · Psychiatry Research
  29. The Key Role of Intracellular 5-HT2A Receptors: A Turning Point in Psychedelic Research?
    Jacopo Sapienza · 2023 · Psychoactives
  30. The influence of stakeholder interests on safety outcome reporting in psychedelic research and implications for science communication
    Elena Koning, Marco Solmi, Elisa Macedo Brietzke · 2024 · Trends in Psychiatry and Psychotherapy
  31. OAV and 5D-ASC for Brazilian Portuguese: A validation and adaptation study
    Rafael Rodrigues, Isabel Wießner, Dimitri Daldegan‐Bueno, Bheatrix Bienemann, Alexandre Augusto de Deus Pontual, Luís Fernando Tófoli, Daniel C. Mograbi · 2025 · Journal of Psychopharmacology
  32. Reviewing the role of emerging therapies in the ADHD armamentarium
    Ann Catherine Childress, Nathalie Beltran, Carl Supnet, Margaret Danielle Weiss · 2020 · Expert Opinion on Emerging Drugs
  33. 3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs
    Raúl López‐Arnau, Jordi Camarasa, Marcel·lí Carbó, Núria Nadal‐Gratacós, Pol Puigseslloses, María Espinosa‐Velasco, Edurne Urquizu, Elena Escubedo, David Pubill · 2022 · Frontiers in Psychiatry
  34. Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis
    Noah D. Gold, Austin J. Mallard, Jacob C. Hermann, Richard J. Zeifman, Broc A. Pagni, Michael P. Bogenschutz, Stephen Ross · 2023 · Journal of Palliative Medicine
  35. Neuroenhancement: State of the Art and Future Perspectives.
    Donatella Marazziti, Maria Teresa Avella, Tea Ivaldi, Stefania Palermo, Lucia Massa, Alessandra Della Vecchia, Lucia Basile, Federico Mucci · 2021 · PubMed Central
  36. Psychological and psychiatric characterization of various groups of drugs users
    Daniela-Mădălina Ciucă Anghel, Elena-Elisabeta Anghel, Miriana Stan, Gheorghe Tudor, Anca Silvia Dumitriu, Stana Păunica, Daniela Luiza Baconi · 2022 · Journal of Mind and Medical Sciences
  37. LSD Modulates Proteins Involved in Cell Proteostasis, Energy Metabolism and Neuroplasticity in Human Cerebral Organoids
    Marcelo N. Costa, Livia Goto‐Silva, Juliana Minardi Nascimento, Ivan Domith, Karina Karmirian, Amanda Feilding, Pablo Trindade, Daniel Martins‐de‐Souza, Stevens Kastrup Rehen · 2024 · ACS Omega
  38. History of psychedelic drug science and molecular pharmacology
    David E. Nichols, Charles David Nichols · 2025 · International review of neurobiology
  39. Analytical profile of N‐ethyl‐N‐cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4‐dimethylazetidide (LSZ)
    Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, Alexander Stratford, Simon P Elliott, Geraldine Dowling, Adam L. Halberstadt · 2020 · Drug Testing and Analysis
  40. Antidepressants
    Richard A. Glennon, Leslie Lars Iversen · 2021 · Wiley eBooks
  41. Microdosing Psychedelics to Restore Synaptic Density in Schizophrenia
    Jacopo Sapienza, Marco Spangaro, Stefano Comai, Michel Sabé, Joseph T. La Torre, Matteo Buonarroti, Roberto Cavallaro, Marta Bosia · 2025 · International Journal of Molecular Sciences
  42. A causal pluralist theory of the interaction of substance, set and setting in psychedelic experience
    Julian D Kiverstein, Hüseyin Beyköylü, Michiel van Elk · 2025 · Philosophical Psychology
  43. Psychedelics in functional disorders: A scoping review
    Chiranth Bhagavan, Olivia L. Carter, Alexander Bryson, Orwa Dandash, Richard Kanaan · 2026 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  44. Urological Implications Associated with the Use of Recreational Drugs: A Narrative Review
    Mudassir Maqbool Wani, Musaab Hamdoon, Greg Dewar, Philippa Buakuma, Sanjeev Madaan · 2022 · Urology Research and Practice
  45. Understanding the Effects of Lysergic Acid Diethylamide and the Importance of Its Prevention
    Burak Okumuş, A. Metin, I. Kariper · 2023 · Health Sciences Review
  46. LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain
    J Van Der Walt, Romy Parker · 2023 · South African Medical Journal
  47. Addiction of Hallucinogens, Dissociatives, Designer Drugs and “Legal Highs”: Update on Potential Therapeutic Use
    Magı́ Farré, Esther Papaseit, Francina Fonseca, Marta Torrens · 2020 · Springer eBooks
  48. Inducing Effects of Illegal Drugs to Improve Mental Health by Self-Regulation Therapy: A Pilot Study
    Salvador Amigó · 2021 · International Journal of Environmental Research and Public Health
  49. Microdosing Psychedelics as a Promising New Pharmacotherapeutic
    Kim P. C. Kuypers · 2021 · Springer eBooks
  50. How to set up a psychedelic study: Unique considerations for research involving human participants
    Marcus J. Glennon, Catherine Bird, Prateek Yadav, Patrick Kleine, Shayam Suseelan, Christina Boman-Markaki, Vasileia Kotoula, Matt Butler, Robert Leech, Leor Roseman et al. · 2026 · Neuroscience & Biobehavioral Reviews
  51. Targeting peripheral 5-HT2AR enhances antitumor immunity in colorectal cancer
    YaTing Wen, LingJie Tang, Wenwen Duan, Qingfei Ren, Yangyue Ni, Shiyang Chen, Jun Chen, Lei Yang, Huan Wang, Yuan Chen et al. · 2026 · Cell
  52. Substance-Induced Psychosis: a Narrative Review
    Lea Tomašić, Mirta Peček, Zrnka Kovačić Petrović · 2023 · Current Addiction Reports
  53. Investigating the impact of psychedelic drugs on social cognition defects: A scoping review protocol
    Sarah Ann Smith, Shaina Smith, Liz Dennett, Yanbo Zhang · 2024 · PLoS ONE
  54. Hallucinations and Imagination
    Daniel Collerton, Elaine King Perry, Alan Robert Bowman · 2020 · Cambridge University Press eBooks
  55. Molecular docking and binding interaction between psychedelic drugs and human serum albumin
    Hossein Khastar, Kobra Foroughi, Seyed Shahrokh Aghayan, Maryam Yarmohammadi, Moslem Jafarisani · 2020 · Biotechnologia
  56. Drugs of Abuse Affecting 5-HT2B Receptors
    Dino Luethi, Matthias E. Liechti · 2021 · The Receptors
  57. Unraveling the Mysteries of Mental Illness With Psilocybin
    R. Sottile, H. Singh, A. Weisman, Thomas A. Vida · 2022 · Cureus
  58. Medication and Substance-Induced Hypertension: Mechanisms and Management
    Sandeep K. Riar, Douglas L. Blowey · 2023 · Springer eBooks
  59. Serotonergic psychedelics for depression: A comprehensive overview
    Wingert, A.M., Agnorelli, C., Peill, J., Reed, S., Nutt, D.J., Erritzoe, D. · 2025 · International Review of Neurobiology
  60. From Outsider to Insider: A Look at the Subculture of Microdosing
    Blake Beaton, Jurg Gerber · 2024 · Deviant Behavior
  61. A Comparative Model of Mysticism: Cognitive Neuroscience, Phenomenal Experiences, and Noetic Accounts
    Hemal P. Trivedi · 2024 · Archive for the Psychology of Religion
  62. Asymmetric Rh-Catalyzed Synthesis of Dihydronicotinamides
    Sara Zerangnasrabad, Rashad R. Karimov · 2025 · The Journal of Organic Chemistry
  63. Modulators of altered states of consciousness across psychedelic, dissociative, and entactogen use: A retrospective naturalistic study using the 5D-ASC
    B. Romeo, Ewen Kervadec, Baptiste Fauvel, Lana Strika-Bruneau, P. Mathieu, Ammar Amirouche, Aurore Bezo, Romain Hacquet, Pascale Piolino, Amine Benyamina · 2026 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  64. Exploring a Decade of Microdosing Research: A Qualitative Meta-synthesis of Microdosing Literature
    Blake Beaton · 2026 · Deviant Behavior
  65. Chainsaw-related sub-decapitation: case report and literature review
    Rachele Turrini, Matilde Bissolo, Riccardo Saccà, Dario Raniero · 2026 · Australian Journal of Forensic Sciences
  66. Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT)
    Heba Diab, Benjamin Malcolm · 2020 · Journal of Psychoactive Drugs
  67. The Potential for Psychedelics to Improve Coping Skills and Resilience in Persons With Newly Diagnosed Mild Cognitive Impairment or Early Alzheimer’s Disease
    Martin I. Steinberg, Paul Rosenberg, Albert Garcia‐Romeu · 2023 · Current Geriatrics Reports
  68. The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits
    Natália Bernardi Videira, Vijayalekshmi Nair, Valérie Paquet, Dean Calhoun · 2023 · Journal of Applied Toxicology
  69. Deciphering the Causality between Gut Microbiota Dysbiosis and Poisoning by Narcotics and Psychodysleptics: A Mendelian Randomization Analysis
    Ning Wang, Zhenbo Su · 2024 · Current Neuropharmacology
  70. A novel psychedelic 5-HT 2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer
    Gerard J. Marek, Soma Makai‐Bölöni, Daniel Umbricht, Edward P. Christian, Jason Winters, Dino Dvořák, Shane R. Raines, Zoë A. Hughes, Eric W. Austin, Adam K. Klein et al. · 2025 · Journal of Psychopharmacology
  71. Overview of the synthetic approaches to lysergic acid as a precursor to the psychedelic LSD
    Michael J. Nutt, Nick Woolf, Scott G. Stewart · 2023 · Australian Journal of Chemistry
  72. Dynamics of acute poisoning with narcotic and psychotropic drugs in children
    V. Kutsenko, D.D. Kovaleva, Nana Revazovna Mironova, Tatyana O. Rumyantseva · 2021 · Russian Pediatric Journal
  73. The Basis For A Neurobiological-Associative Model of Personality and Group Cohesion: The Evolutionary And System Biological Origins Of Social Exclusion, Hierarchy, and Structure
    Michael E. Thomas · 2020 · Preprints.org
  74. Psychological Antecedents to the Effects of Psychedelics on Workplace Productivity: Interview Evidence of a Naturalistic Setting
    Greg Ferenstein · 2021 · SSRN Electronic Journal
  75. Lysergic Acid Amide (LSA), an LSD Analog: Systematic Review of Pharmacological Effects, Adverse Outcomes, and Therapeutic Potentials
    Paula S. C. C. Castro, Kaê Leopoldo, Maria Olívia Pozzolo Pedro, Juliana Takitane, Henrique Silva Bombana, André Brooking Negrão, Jaqueline Schölz Issa, João Maurício Castaldelli-Maia · 2025 · Pharmacy
  76. Psychedelics in Focus: Clinical Trial Advancements, USFDA Breakthrough Designations, Innovative Approaches, Legal and Regulatory Aspects
    Gadekar Kailas Vijay, Ramesh Joga, Sravani Yerram, Sonali Waiker, Kajal Gandhi, M Sowndharya, Saurabh Srivastava · 2026 · Journal of Pharmaceutical Innovation
  77. The metabolism of indoleamines
    Mark David Tricklebank, Daniel Martins · 2019 · Elsevier eBooks
  78. Substances of Abuse and the Brain
    Alisha R. Moreland-Capuia · 2019 · Springer eBooks
  79. Møter med det hellige: bruk av LSD,fleinsopp og andre psykedeliske stoffer
    Willy Pedersen · 2020 · Tidsskrift for samfunnsforskning
  80. Cognition Enhancers, Psychostimulants, and Psychedelic Drugs
    Vimala Ananthy · 2021 · Introduction to Basics of Pharmacology and Toxicology
  81. Lysergic acid diethylamide: In search of the wonder drug
    Mihai Avram, Felix Müller, Stefan Borgwardt · 2023 · Oxford University Press eBooks
  82. Adli Toksikoloji: Temel Kavramlar ve Prensipler
    Işıl Bavunoğlu, Merve Kuloğlu Genç, Murat Yayla, Münevver Açıkkol, Simge Zengin, Sümeyye Zülal Şimşek, Tuğba Tekin Bülbül, Zeynep Arslan · 2023
  83. Adli Toksikolojide Analiz Yöntemleri
    Tuğba Tekin Bülbül, Zeynep Türkmen · 2023
  84. Women’s Drug Use in Everyday Life
    Emma Eleonorasdotter · 2023 · Springer eBooks
  85. The Neurochemical Bases of Verbal Suggestion and Hypnosis
    Derek M. Smith, David J. Acunzo, Quinton Deeley, Mitul Ashok Mehta, Devin Blair Terhune · 2024 · Routledge eBooks
  86. Linking Substance Use and Schizophrenia
    Emre Mutlu, Hayri Can Özden, Aygün Ertuğrul · 2024 · Springer eBooks
  87. Rural‐urban divide in risk perception of LSD: Implications for psychedelic‐assisted therapy
    Melissa Bradley, Daniel Grossman, Otto Simonsson, Heith Copes, Peter S. Hendricks · 2024 · The Journal of Rural Health
  88. Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows
    Lou Vinarcsik, Charles Smoller, George Thomas Grossberg · 2025 · Drugs & Aging
  89. An apathetic child with hallucinations
    Ingrid Anna Teigen, Jon Andsnes Berg, Kristoffer Brodwall · 2021 · Tidsskrift for Den norske legeforening
  90. Psychodeliki - lepsza alternatywa leczenia depresji?
    Krystyna Gołembiowska · 2021 · Nauka
  91. Journey To The Centre Of The Mind: Psychedelic Treatment of Mental Health in Aotearoa
    Daisy Lutyens · 2023
  92. Understanding Steve Jobs from Psychiatric Perspectives
    Tam ngoc Nguyen · 2019
  93. Analysis of the self-ignition of a turbulent gas jet in a stream of oxidizing agent
    V. N. Strokin · 1972 · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
  94. Le premier « trip » d’un enfant de 26 mois documenté par CL-SMHR
    Jenny Becam, Anne-Marie Zoccarato, Guillaume Roux, Emilie Doudon, Magali Richez, Carole Pourriere-Fabiani, Bruno Lacarelle, Caroline Solas, Nicolas Fabresse · 2021 · Annales de Toxicologie Analytique
  95. Redes cerebrais estruturais e funcionais: das conexões à cognição. Um estudo aplicado em doença cerebral de pequenos vasos
    Pedro Henrique Rodrigues da Silva · 2022
  96. Hallucinogenic Drugs
    Katherine R. Bonson · 2020 · Encyclopedia of Life Sciences
  97. Understanding Steve Jobs from Psychiatric Perspectives
    Tam ngoc Nguyen · 2019
  98. Medication and Substance-Induced Hypertension: Mechanisms and Management
    Sandeep K. Riar, Douglas L. Blowey · 2022 · Springer eBooks
  99. INVITED EDITORIAL: Sharing Effective Models of Student Research Mentoring: Stories From Associate Editors
    Robert R. Wright, Kimberli R. H. Treadwell, Jennifer L. Hughes · 2022 · Psi Chi Journal of Psychological Research
  100. LSD et MDMA en combinaison (Candy Flip)
    Pierre Poloméni · 2023 · Psychotropes